JP Morgan recommends investors focus on UK oil supermajors BP and Shell during the Q3 reporting season due to strong earnings prospects driven by refining operations and ongoing Middle East geopolitical risks. The bank prefers these companies over TotalEnergies and holds an overweight view on Eni and Galp, citing their sensitivity to oil prices and operational improvements. While European oil stocks have outperformed recently, JP Morgan is cautious about midcap European energy firms due to signs of weakening refining margins and advises selectivity in that segment. The outlook reflects a positive free cash flow yield and earnings growth above consensus for 2027, supported by stable Brent crude prices and refining margins.
JP Morgan's preference for UK supermajors amid oil market risks is noted here with Pluang's Energy sector data as context. For readers following energy stocks, as of Oct 08, 2026 19:13 WIB, 40 of 62 priced US energy stocks on Pluang rose while 20 fell. Notable movers include EQNR at USD 42.96 with a 3.24% gain and a typical hold time of 59 days, SM Energy Company at USD 36.34 up 3.09%, and Vista Energy at USD 67.39 up 3.00%.
MIND, an AI-native data loss prevention (DLP) platform, was named "Data Loss Prevention Platform of the Year" in the 2026 CyberSecurity Breakthrough Awards. The platform uses advanced AI to discover, detect, and prevent sensitive data leaks across va...
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
